Find Research outputs

Search results

• Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy

  Cunningham, E. B., Hajarizadeh, B., Amin, J., Litwin, A. H., Gane, E., Cooper, C., Lacombe, K., Hellard, M., Read, P., Powis, J., Dalgard, O., Bruneau, J., Matthews, G. V., Feld, J. J., Dillon, J. F., Shaw, D., Bruggmann, P., Conway, B., Fraser, C., Marks, P. & 2 others, Dore, G. J. & Grebely, J., 1 Oct 2020, In: Clinical Infectious Diseases. 71, 7, p. e115-e124 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepatitis C
  • Opioid Analgesics
  • Antiviral Agents
  • Injections
  • Infection
  6 Citations (Scopus)

  30 Downloads (Pure)

• Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

  Cunningham, E. B., Amin, J., Feld, J. J., Bruneau, J., Dalgard, O., Powis, J., Hellard, M., Cooper, C., Read, P., Conway, B., Dunlop, A. J., Norton, B., Litwin, A. H., Hajarizadeh, B., Thurnheer, M. C., Dillon, J. F., Weltman, M., Shaw, D., Bruggmann, P., Gane, E. & 8 others, Fraser, C., Marks, P., Applegate, T. L., Quiene, S., Siriragavan, S., Matthews, G. V., Dore, G. J. & Grebely, J., Dec 2018, In: International Journal of Drug Policy. 62, p. 14-23 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • velpatasvir
  • Sofosbuvir
  • Injections
  • Infection
  • Pharmaceutical Preparations
  22 Citations (Scopus)

  77 Downloads (Pure)

• A genome-wide association study identifies potential susceptibility Loci for hepatotoxicity due to various drugs

  Urban, T., Shen, Y., Chalasani, N. P., Fontana, R. J., Rochon, J., Stolz, A., Serrano, J. A., Aithal, G. P., Daly, A., Dillon, J. F., Floraros, A., Molokhia, M., Lucena, M. I., Goldstein, D. B. & Watkins, P. B., May 2011, In: Gastroenterology. 140, 5 Suppl. 1, p. S886-S886 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Application of a discrete choice experiment approach to support the design of a hepatitis C testing service in primary care

  Radley, A., van der Pol, M. & Dillon, J., Mar 2019, In: International Journal of Drug Policy. 65, p. 1-7 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Opiate Substitution Treatment
  • Hepatitis C
  • Primary Health Care
  • Respect
  • Pharmacy
  4 Citations (Scopus)

  105 Downloads (Pure)

• A systematic review and meta-analysis of community and primary-care-based hepatitis C testing and treatment services that employ direct acting antiviral drug treatments

  Radley, A., Robinson, E., Aspinall, E. J., Angus, K., Tan, L. & Dillon, J., 28 Oct 2019, In: BMC Health Services Research. 19, 1, p. 1-13 13 p., 765.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepatitis C
  • Antiviral Agents
  • Primary Health Care
  • Meta-Analysis
  • Systematic Reviews
  12 Citations (Scopus)

  114 Downloads (Pure)

• Bacterial translocation in cirrhosis is not caused by an abnormal small bowel gut microbiota

  Steed, H., Macfarlane, G. T., Blackett, K. L., Macfarlane, S., Miller, M. H., Bahrami, B. & Dillon, J. F., Dec 2011, In: FEMS Immunology and Medical Microbiology. 63, 3, p. 346-354 9 p.

  Research output: Contribution to journal › Article › peer-review
  15 Citations (Scopus)

• Barrett's esophagus: proton pump inhibitors and chemoprevention I

  Triadafilopoulos, G., Taddei, A., Bechi, P., Freschi, G., Ringressi, M. N., Degli'Innocenti, D. R., Castiglione, F., Masini, E., Majewski, M., Wallner, G., Sarosiek, J., Dillon, J. F., Mccallum, R. C., Dvorak, K., Goldman, A., Woodland, P., Sifrim, D., Richter, J. E., Vieth, M., Neumann, H. & 4 others, Langner, C., Ishimura, N., Amano, Y. & Felix, V. N., Sep 2011, In: Annals of the New York Academy of Sciences. 1232, 1, p. 93-113 21 p.

  Research output: Contribution to journal › Article › peer-review

  • Chemoprevention
  • Barrett Esophagus
  • Proton Pump Inhibitors
  • Normalization
  • Therapy
  2 Citations (Scopus)

• Change in injecting behaviour among people treated for hepatitis C virus: the role of intimate partnerships

  Malaguti, A., Sani, F., Stephens, B. P., Ahmad, F., Dugard, P. & Dillon, J., 1 Jan 2019, In: Journal of Viral Hepatitis. 26, 1, p. 65-72 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepacivirus
  • Virus Diseases
  • Pharmaceutical Preparations
  • Therapeutics
  • Psychology
  1 Citation (Scopus)

  74 Downloads (Pure)

• Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial

  Radley, A., De Bruin, M., Inglis, S. K., Donnan, P. T., Hapca, A., Barclay, S. T., Fraser, A. & Dillon, J. F., Sep 2020, In: Lancet Gastroenterology and Hepatology. 5, 9, p. 809-818 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Opiate Substitution Treatment
  • Pharmacists
  • Hepacivirus
  • Antiviral Agents
  • Pharmacies
  4 Citations (Scopus)

• Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomised trial

  Radley, A., de Bruin, M., Inglis, S. K., Donnan, P. T. & Dillon, J. F., 14 Dec 2018, In: BMJ Open. 8, 12, p. 1-8 8 p., e021443.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Opiate Substitution Treatment
  • Hepatitis C
  • Pharmacy
  • Pharmacists
  • Hepacivirus
  7 Citations (Scopus)

  158 Downloads (Pure)

• Commentary: assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers

  Miller, M. H. & Dillon, J. F., 1 Jan 2013, In: Alimentary Pharmacology & Therapeutics. 37, 2, p. 275 1 p.

  Research output: Contribution to journal › Article › peer-review
  1 Citation (Scopus)

• Commentary: vancomycin or metronidazole in patients with primary sclerosing cholangitis?

  Paterson, J. C. M. & Dillon, J. F., May 2013, In: Alimentary Pharmacology & Therapeutics. 37, 9, p. 915 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review
  1 Citation (Scopus)

• Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease

  Spanos, C., Maldonado, E. M., Fisher, C. P., Leenutaphong, P., Oviedo-Orta, E., Windridge, D., Salguero, F. J., Bermúdez-Fajardo, A., Weeks, M. E., Evans, C., Corfe, B. M., Rabbani, N., Thornalley, P. J., Miller, M. H., Wang, H., Dillon, J. F., Quaglia, A., Dhawan, A., Fitzpatrick, E. & Moore, J. B., 25 Jun 2018, In: Proteome Science. 16, 13, p. 13 1 p., 13.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  File

  • Proteomics
  • Liver
  • Non-alcoholic Fatty Liver Disease
  128 Downloads (Pure)

• Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review

  Brennan, P., Clare, K., George, J. & Dillon, J. F., 21 Apr 2020, In: World Journal of Gastroenterology . 26, 15, p. 1683-1690 8 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Non-alcoholic Fatty Liver Disease
  • Fatty Liver
  • Uric Acid
  • Biomarkers
  • Metabolic Syndrome
  2 Citations (Scopus)

  56 Downloads (Pure)

• Development and validation of diagnostic triage criteria for liver disease from a minimum data set enabling the 'intelligent LFT' pathway for the automated assessment of deranged liver enzymes

  Miller, M. H., Fraser, A., Leggett, G., MacGilchrist, A., Gibson, G., Orr, J., Forrest, E. H., Dow, E., Bartlett, W., Weatherburn, C., Laurell, A., Grant, K., Scott, K., Neville, R. & Dillon, J. F., Jul 2018, In: Frontline Gastroenterology. 9, 3, p. 175-182 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Liver Function Tests
  • Triage
  • Liver Diseases
  • Datasets
  • Primary Health Care
  3 Citations (Scopus)

  261 Downloads (Pure)

• Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK

  Williams, R., Alexander, G., Armstrong, I., Baker, A., Bhala, N., Camps-Walsh, G., Cramp, M. E., de Lusignan, S., Day, N., Dhawan, A., Dillon, J., Drummond, C., Dyson, J., Foster, G., Gilmore, I., Hudson, M., Kelly, D., Langford, A., McDougall, N., Meier, P. & 14 others, Moriarty, K., Newsome, P., O'Grady, J., Pryke, R., Rolfe, L., Rice, P., Rutter, H., Sheron, N., Taylor, A., Thompson, J., Thorburn, D., Verne, J., Wass, J. & Yeoman, A., 17 Mar 2018, In: Lancet. 391, 10125, p. 1097-1107 11 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Cost of Illness
  • Hepatitis
  • Industry
  • Alcohol Drinking
  • Liver Diseases
  63 Citations (Scopus)

  553 Downloads (Pure)

• Does geographic access to primary healthcare influence the detection of hepatitis C?

  Astell-Burt, T., Flowerdew, R., Boyle, P. J. & Dillon, J. F., 2011, In: Social Science and Medicine. 72, 9, p. 1472-1481 10 p.

  Research output: Contribution to journal › Article › peer-review
  15 Citations (Scopus)

• Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles

  Nicoletti, P., Aithal, G. P., Chamberlain, T. C., Coulthard, S. A., Alshabeeb, M., Grove, J. I., Andrade, R. J., Bjornsson, E. S., Dillon, J. F., Hallberg, P., Lucena, M. I., Maitland-van der Zee, A. H., Martin, J. H., Molokhia, M., Pirmohamed, M., Wadelius, M., Shen, Y., Nelson, M. R. & Daly, A. K., Jul 2019, In: Clinical Pharmacology & Therapeutics. 106, 1, p. 245-253 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Floxacillin
  • Chemical and Drug Induced Liver Injury
  • HLA Antigens
  • Alleles
  • Penicillins
  17 Citations (Scopus)

  138 Downloads (Pure)

• Editorial: there is trouble ahead, but just how much? The troubling reality of America's excesses and NAFLD

  Brennan, P. N. & Dillon, J. F., Jan 2018, In: Alimentary Pharmacology & Therapeutics. 47, 2, p. 299-300 2 p.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access

• Effectiveness of the use of implementation intentions on reduction of substance use: A meta-analysis

  Malaguti, A., Ciocanel, O., Sani, F., Dillon, J. F., Eriksen, A. J. & Power, K., 1 Sep 2020, In: Drug and Alcohol Dependence. 214, p. 1-11 11 p., 108120.

  Research output: Contribution to journal › Article › peer-review

  • Tobacco
  • Intention
  • Meta-Analysis
  • Alcohols
  • Street Drugs

• Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection

  Zuckerman, E., Gutierrez, J. A., Dylla, D. E., de Ledinghen, V., Muir, A. J., Gschwantler, M., Puoti, M., Caruntu, F., Slim, J., Nevens, F., Sigal, S., Cohen, S., Fredrick, L. M., Pires Dos Santos, A. G., Rodrigues, L. & Dillon, J. F., Oct 2020, In: Clinical Gastroenterology and Hepatology. 18, 11, p. 2544-2553.e6 16 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • pibrentasvir
  • ABT-493
  • Hepacivirus
  • Fibrosis
  • Virus Diseases
  3 Citations (Scopus)

  23 Downloads (Pure)

• Eradicating hepatitis C: Are novel screening strategies for people who inject drugs cost-effective?

  Manca, F., Robinson, E., Dillon, J. F. & Boyd, K. A., Aug 2020, In: International Journal of Drug Policy. 82, p. 1-10 10 p., 102811.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Drug Costs
  • Hepatitis C
  • Hepacivirus
  • Costs and Cost Analysis
  • Quality-Adjusted Life Years
  1 Citation (Scopus)

  50 Downloads (Pure)

• Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe): a natural experiment (protocol)

  Hickman, M., Dillon, J., Elliott, L., De Angelis, D., Vickerman, P., Foster, G., Donnan, P., Eriksen, A., Flowers, P., Goldberg, D., Hollingworth, W., Ijaz, S., Liddell, D., Mandal, S., Martin, N., Beer, L., Drysdale, K., Fraser, H., Glass, R., Graham, L. & 29 others, Gunson, R. N., Hamilton, E., Harris, H., Harris, M., Harris, R., Heinsbroek, E., Hope, V., Horwood, J., Inglis, S., Innes, H., Lane, A., Meadows, J., McAuley, A., Metcalfe, C., Migchelsen, S., Murray, A., Myring, G., Palmateer, N. E., Presanis, A., Radley, A., Ramsay, M., Samartsidis, P., Simmons, R., Sinka, K., Vojt, G., Ward, Z., Whiteley, D., Yeung, A. & Hutchinson, S. J., 24 Sep 2019, In: BMJ Open. 9, 9, 12 p., e029538.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepatitis C
  • Hepacivirus
  • Antiviral Agents
  • Pharmaceutical Preparations
  • Population
  5 Citations (Scopus)

  91 Downloads (Pure)

• Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care

  Innes, H. A., Hutchinson, S. J., Allen, S. H., Bhattacharyya, D., Bramley, P., Delahooke, T. E. S., Dillon, J. F., Forrest, E., Fraser, A., Gillespie, R., Goldberg, D. J., Kennedy, N., McDonald, S., McLeod, A., Mills, P. R., Morris, J. & Hayes, P., Nov 2011, In: Hepatology. 54, 5, p. 1547-1558

  Research output: Contribution to journal › Article › peer-review
  56 Citations (Scopus)

• Excess morbidity in the hepatitis C-diagnosed population in Scotland, 1991-2006

  McDonald, S. A., Hutchinson, S. J., Bird, S. M., Mills, P. R., Hayes, P., Dillon, J. F. & Goldberg, D. J., 2011, In: Epidemiology and Infection. 139, 3, p. 344-353 10 p.

  Research output: Contribution to journal › Article › peer-review
  14 Citations (Scopus)

• Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2)

  Sharma, R. S., Harrison, D. J., Kisielewski, D., Cassidy, D. M., McNeilly, A. D., Gallagher, J. R., Walsh, S. V., Honda, T., McCrimmon, R. J., Dinkova-Kostova, A. T., Ashford, M. L. J., Dillon, J. F. & Hayes, J. D., 1 Mar 2018, In: CMGH: Cellular and Molecular Gastroenterology and Hepatology. 5, 3, p. 367-398 32 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • TBE 31
  • NF-E2-Related Factor 2
  • Fructose
  • Non-alcoholic Fatty Liver Disease
  • Liver Cirrhosis
  63 Citations (Scopus)

  171 Downloads (Pure)

• Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK

  Williams, R., Alexander, G., Aspinall, R., Batterham, R., Bhala, N., Bosanquet, N., Severi, K., Burton, A., Burton, R., Cramp, M. E., Day, N., Dhawan, A., Dillon, J., Drummond, C., Dyson, J., Foster, G. R., Gilmore, I., Greenberg, J., Henn, C., Hudson, M. & 18 others, Jarvis, H., Kelly, D., Mann, J., McDougall, N., McKee, M., Moriarty, K., Morling, J., Newsome, P., O'Grady, J., Rolfe, L., Rice, P., Rutter, H., Sheron, N., Thorburn, D., Verne, J., Vohra, J., Wass, J. & Yeoman, A., 1 Dec 2018, In: Lancet. 392, 10162, p. 2398-2412 15 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Liver Diseases
  • Alcohols
  • National Health Programs
  • Obesity
  • England
  28 Citations (Scopus)

  455 Downloads (Pure)

• Genome-wide Association Study for Alcohol-related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1

  Innes, H., Buch, S., Hutchinson, S., Guha, I. N., Morling, J. R., Barnes, E., Irving, W., Forrest, E., Pedergnan, V., Goldberg, D., Aspinall, E., Barclay, S., Hayes, P., Dillon, J., Nischalke, H. D., Lutz, P., Spengler, U., Fischer, J., Berg, T., Brosch, M. & 11 others, Eyer, F., Datz, C., Mueller, S., Peccerella, T., Deltenre, P., Marot, A., Soyka, M., McQuillin, A., Morgan, M. Y., Hampe, J. & Stickel, F., Oct 2020, In: Gastroenterology. 159, 4, p. 1276-1298.e7 21 p.

  Research output: Contribution to journal › Article › peer-review

  • amidoxime
  • Heterogeneous-Nuclear Ribonucleoprotein U
  • Gene Components
  • Genome-Wide Association Study
  • Alcohols

• Guidelines on the management of abnormal liver blood tests

  Newsome, P. N. G., Cramb, R., Davison, S. M., Dillon, J. F., Foulerton, M., Godfrey, E. M., Hall, R., Harrower, U., Hudson, M., Langford, A., Mackie, A., Mitchell-Thain, R., Sennett, K., Sheron, N. C., Verne, J., Walmsley, M. & Yeoman, A., Jan 2018, In: Gut. 67, 1, p. 6-19 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hematologic Tests
  • Guidelines
  • Gastroenterology
  • Liver
  • Biochemistry
  86 Citations (Scopus)

  215 Downloads (Pure)

• HCV research UK: a UK national resource to support research into HCV infection

  Irving, W., McLauchlan, J., Foster, G., Dillon, J., Hutchinson, S. & Wilkes, B., Jul 2012, In: Gut. 61, Suppl. 2, p. A147-A148 2 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Hepatitis C Diagnosis and Treatment, Impact on Engagement and Behaviour of People Who Inject Drugs, a service evaluation, the Hooked C project

  Caven, M., Robinson, E. M., Eriksen, A. J., Fletcher, E. H. & Dillon, J. F., 13 May 2020, In: Journal of Viral Hepatitis. 27, 6, p. 576-584 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepatitis C
  • Pharmaceutical Preparations
  • Mortality
  • Polymerase Chain Reaction
  • Antiviral Agents
  42 Downloads (Pure)

• Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework

  Day, E., Hellard, M., Treloar, C., Bruneau, J., Martin, N. K., Øvrehus, A., Dalgard, O., Lloyd, A., Dillon, J., Hickman, M., Byrne, J., Litwin, A., Maticic, M., Bruggmann, P., Midgard, H., Norton, B., Trooskin, S., Lazarus, J. V. & Grebely, J., 1 Jan 2019, In: Liver International. 39, 1, p. 20-30 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepatitis C
  • Health
  • Pharmaceutical Preparations
  • Healthcare Financing
  • Federal Government
  24 Citations (Scopus)

  67 Downloads (Pure)

• Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis

  Hajarizadeh, B., Cunningham, E. B., Valerio, H., Martinello, M., Law, M., Janjua, N., Midgard, H., Dalgard, O., Dillon, J., Hickman, M., Bruneau, J., Dore, G. J. & Grebely, J., Apr 2020, In: Journal of Hepatology. 72, 4, p. 643-657 15 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepatitis C
  • Antiviral Agents
  • Meta-Analysis
  • Opioid Analgesics
  • Pharmaceutical Preparations
  9 Citations (Scopus)

  22 Downloads (Pure)

• Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals

  Martin, N. K., Vickerman, P., Grebely, J., Hellard, M., Hutchinson, S. J., Lima, V. D., Foster, G. R., Dillon, J. F., Goldberg, D. J., Dore, G. J. & Hickman, M., Nov 2013, In: Hepatology. 58, 5, p. 1598-1609 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Drug Design
  • Hepacivirus
  • Antiviral Agents
  • Pharmaceutical Preparations
  • Opiate Alkaloids
  341 Citations (Scopus)

• High response and re-infection rates among people who inject drugs treated for hepatitis C in a community needle and syringe programme

  Schulkind, J., Stephens, B., Ahmad, F., Johnston, L., Hutchinson, S., Thain, D., Ward, Z., Vickerman, P., Hickman, M. & Dillon, J. F., May 2019, In: Journal of Viral Hepatitis. 26, 5, p. 519-528 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Syringes
  • Hepatitis C
  • Needles
  • Hepacivirus
  • Genotype
  20 Citations (Scopus)

  223 Downloads (Pure)

• Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infection

  McDonald, S. A., Hutchinson, S. J., Bird, S. M., Robertson, C., Mills, P. R., Dillon, J. F. & Goldberg, D. J., Jan 2011, In: International Journal of Drug Policy. 22, 1, p. 63-69 7 p.

  Research output: Contribution to journal › Article › peer-review
  5 Citations (Scopus)

• Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings: what is required to achieve the WHO's HCV elimination targets?

  Ward, Z., Platt, L., Sweeney, S., Hope, V. D., Maher, L., Hutchinson, S., Palmateer, N., Smith, J., Craine, N., Taylor, A., Martin, N., Ayres, R., Dillon, J., Hickman, M. & Vickerman, P., Sep 2018, In: Addiction. 113, 9, p. 1727-1738 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Opiate Substitution Treatment
  • Hepatitis C
  • Hepacivirus
  • Pharmaceutical Preparations
  • Syringes
  16 Citations (Scopus)

  139 Downloads (Pure)

• Impact of Hepatitis C treatment on behavioural change in relation to drug use in people who inject drugs: A systematic review

  Caven, M., Malaguti, A., Robinson, E., Fletcher, E. & Dillon, J. F., Oct 2019, In: International Journal of Drug Policy. 72, p. 169-176 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepatitis C
  • Systematic Reviews
  • Pharmaceutical Preparations
  • Syringes
  • Therapeutics
  9 Citations (Scopus)

  77 Downloads (Pure)

• Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysis

  Wang, H., Swann, R., Thomas, E., Innes, H. A., Valerio, H., Hayes, P. C., Allen, S., Barclay, S. T., Wilks, D., Fox, R., Bhattacharyya, D., Kennedy, N., Morris, J., Fraser, A., Stanley, A. J., Gunson, R., Mclntyre, P. G., Hunt, A., Hutchinson, S. J., Mills, P. R. & 1 others, Dillon, J. F., 1 Aug 2018, In: Journal of Viral Hepatitis. 25, 8, p. 930-938 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Chronic Hepatitis C
  • Hepatitis B
  • Hepacivirus
  • Hepatitis B virus
  • Liver
  5 Citations (Scopus)

  152 Downloads (Pure)

• Increased case-finding and uptake of direct-acting antiviral treatment essential for micro-elimination of hepatitis C among people living with HIV: a national record linkage study

  McLeod, A., Hutchinson, S. J., Smith, S., Leen, C., Clifford, S., McAuley, A., Wallace, L. A., Barclay, S. T., Bramley, P., Dillon, J. F., Fraser, A., Gunson, R. N., Hayes, P. C., Kennedy, N., Peters, E., Templeton, K. & Goldberg, D. J., 17 Dec 2020, In: HIV medicine. 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Hepatitis C
  • Hepacivirus
  • Antiviral Agents
  • HIV
  • Chronic Hepatitis C

• Increasing survival of hepatocellular carcinoma patients in Scotland: a review of national cancer registry data

  Dunbar, J. K., Dillon, J., Garden, J. & Brewster, D. H., 1 Apr 2013, In: HPB. 15, 4, p. 279-285 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Scotland
  • Hepatocellular Carcinoma
  • Registries
  • Survival
  • Neoplasms
  7 Citations (Scopus)

• Intelligent Liver Function Testing: Working Smarter to Improve Patient Outcomes in Liver Disease

  Macpherson, I., Nobes, J. H., Dow, E., Furrie, E., Miller, M. H., Robinson, E. M. & Dillon, J. F., Sep 2020, In: Journal of Applied Laboratory Medicine. 5, 5, p. 1090-1100 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Liver Diseases
  • Liver Function Tests
  • Liver
  • Scotland
  • Hematologic Tests
  15 Downloads (Pure)

• Intelligent Liver Function Testing (iLFT): A trial of automated diagnosis and staging of liver disease in Primary Care

  Dillon, J. F., Miller, M. H., Robinson, E. M., Hapca, A., Rezaeihemami, M., Weatherburn, C., McIntyre, P. G., Bartlett, B., Donnan, P. T., Boyd, K. A. & Dow, E., Oct 2019, In: Journal of Hepatology. 71, 4, p. 699-706 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Liver Diseases
  • Primary Health Care
  • Liver Function Tests
  • Liver
  • Costs and Cost Analysis
  4 Citations (Scopus)

  41 Downloads (Pure)

• Interferon lambda 4 impacts the genetic diversity of hepatitis C virus

  Ansari, M. A., Aranday-Cortes, E., Ip, C. L. C., da Silva Filipe, A., Lau, S. H., Bamford, C., Bonsall, D., Trebes, A., Piazza, P., Sreenu, V., Cowton, V. M., STOP-HCV Consortium, Hudson, E., Bowden, R., Patel, A. H., Foster, G. R., Irving, W. L., Agarwal, K., Thomson, E. C., Simmonds, P. & 6 others, Klenerman, P., Holmes, C., Barnes, E., Spencer, C. C. A., McLauchlan, J. & Pedergnana, V., 3 Sep 2019, In: eLife. 8, p. 1-23 23 p., e42463.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Viruses
  • Genetic Variation
  • Hepacivirus
  • Interferons
  • Viral Genome
  9 Citations (Scopus)

  90 Downloads (Pure)

• Intravenous drug use: not a barrier to achieving a sustained virological response in HCV infection

  Jafferbhoy, H., Miller, M. H., Dunbar, J. K., Tait, J., Mcleod, S. & Dillon, J. F., Feb 2012, In: Journal of Viral Hepatitis. 19, 2, p. 112-119 8 p.

  Research output: Contribution to journal › Article › peer-review
  12 Citations (Scopus)

• Is it worth testing unstable drug users for Hepatitis C?

  Stephens, B. P., Tait, J. & Dillon, J. F., Oct 2011, In: Hepatology. 54, S1, p. 844A-844A 1 p.

  Research output: Contribution to journal › Special issue › peer-review
  1 Citation (Scopus)

• Is travel-time to a specialist centre a risk factor for non-referral, non-attendance and loss to follow-up among patients with hepatitis C (HCV) infection?

  Astell-Burt, T., Flowerdew, R., Boyle, P. & Dillon, J., 1 Jan 2012, In: Social Science and Medicine.

  Research output: Contribution to journal › Article › peer-review

  • Time Travel
  • Virus
  • Hepatitis C
  • contagious disease
  • Hepacivirus
  14 Citations (Scopus)

• Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe"

  Fraser, H., Martin, N. K., Brummer-Korvenkontio, H., Carrieri, P., Dalgard, O., Dillon, J., Goldberg, D., Hutchinson, S., Jauffret-Roustide, M., Kåberg, M., Matser, A. A., Matičič, M., Midgard, H., Mravcik, V., Øvrehus, A., Prins, M., Reimer, J., Robaeys, G., Schulte, B., van Santen, D. K. & 3 others, Zimmermann, R., Vickerman, P. & Hickman, M., 1 Mar 2018, In: Journal of Hepatology. 68, 3, p. 402-411 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepacivirus
  • Opiate Substitution Treatment
  • Pharmaceutical Preparations
  • Syringes
  • Slovenia
  54 Citations (Scopus)

  150 Downloads (Pure)

• New Horizons in Hepatitis B and C in the Older Adult

  Kemp, L., Clare, K. E., Brennan, P. N. & Dillon, J. F., 1 Jan 2019, In: Age and Ageing. 48, 1, p. 32-37 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepatitis C
  • Hepatitis B
  • Sexual Partners
  • Infection Control
  • Infection
  75 Downloads (Pure)

• Novel non-invasive scoring system for the detection of NASH from a NAFLD population

  Miller, M., Jafferbhoy, H., Crowther, D., Walsh, S., Ferguson, M. A. & Dillon, J. F., Oct 2011, In: Hepatology. 54, p. 1113A-1113A 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
  1 Citation (Scopus)